{"id":"W7010248366","doi":"","title":"HIGH-DOSE WEEKLY CARFILZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE IN THE TREATMENT OF PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA – EXPLORING THE FINANCIAL COST AND RARE SIDE-EFFECTS","year":2021,"lang":"en","type":"dissertation","venue":"QSpace (Queen's University Library)","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"MorphoSys; Celgene; Gilead Sciences; Amgen","keywords":"Carfilzomib; Multiple myeloma; Clinical trial; Dexamethasone; Cyclophosphamide; Clinical endpoint; Refractory (planetary science); Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006369753,0.0001890576,0.0005958507,0.0002654284,0.0002070679,0.0004613039,0.0003057299,0.0003966179,0.001789244],"category_scores_gemma":[0.0006112631,0.00008510359,0.0004456785,0.0003901266,0.000259137,0.0003460856,0.0001839422,0.001055527,0.0001496502],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001219066,"about_ca_system_score_gemma":0.0009894001,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002842921,"about_ca_topic_score_gemma":0.01853065,"domain_scores_codex":[0.9997445,0.0001068707,0.00001773751,0.00002986551,0.00006592371,0.00003507809],"domain_scores_gemma":[0.9996536,0.00006491198,0.00008865928,0.00001156393,0.00002941578,0.0001517934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.06064387,0.004222827,0.04805274,0.001243813,0.0008519687,0.0004704385,0.000188863,0.00173333,0.008633195,0.0007563783,0.0111387,0.8620638],"study_design_scores_gemma":[0.1292224,0.2302279,0.4998306,0.002265252,0.003072388,0.003011646,0.0007727891,0.006576749,0.005293747,0.002944341,0.1165997,0.0001824356],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8447741,0.1300757,0.000558675,0.01231486,0.0005779096,0.0007039189,0.0005020755,0.0000434107,0.01044928],"genre_scores_gemma":[0.9657164,0.02702338,0.001450472,0.003223243,0.0005368235,0.00021376,0.0003194268,0.00000676977,0.001509681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9971571,"threshold_uncertainty_score":0.008844972,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01036265128458165,"score_gpt":0.209194209483576,"score_spread":0.1988315581989944,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}